Abstract-Semax (MEHFPGP) was shown to increase gastric mucosal homeostasis to the action of such ulcerogenic factors as ethanol and stress. In the case of the stress model of ulcer formation, Semax and its two metabolites-HFPGP and FPGP-at the wide range of doses (0.06-3.7 µmol/kg) have demonstrated pro tective antiulcerogenic properties. In the case of ethanol model of ulcer formation, only Semax in two used doses (0.06 and 0.37 µmol/kg) reported reliable protective antiulcerogenic property. It was supposed that Semax's gastroprotective activity directed to peripheral mechanisms of ulcerogenesis did not depend on its metabolites' activities. On the contrary, Semax's gastroprotective activity directed to the central mechanisms of ulcerogenesis might be also caused by gastroprotective activities of HFPGP and FPGP metabolites.
INTRODUCTION
Semax has been synthesized via addition of Pro Gly Pro sequence to the C end of unstable Met Glu His Phe peptide-fragment of adrenocorticotropic hormone ACTH (4-7). Peptide MEHFPGP synthe sized as reported above demonstrated high resistance to proteases action that allowed to significantly increase the duration of its action (Ashmarin et al., 1997) .
Semax characterized by the absence of hormonal activity was shown to stimulate animals' training in differ ent tests-in normal animals and in those with pathology (Yasnetsov et al., 1995; Ashmarin et al., 1997) -to dem onstrate antihypoxic and antiamnestic properties (Kaplan et al., 1992; Yasnetsov et al., 1998) and to improve blood circulation in human and animals (Ashmarin et al., 1997; Khugaeva and Aleksandrin, 1997) . In clinical practices Semax was used for patients' treatment with ischemic apoplexy (Myasoedov et al., 1999) .
According to the study of Semax, influence on pro cesses of blood coagulation and thrombosis and con junction of PGP sequence to AKTG 4-7 resulted in both increase in its preliminary biological activity and in its addition with PGP effects. Thus, Semax was shown to possess somewhat lower (compared to glyprolines) but significantly marked anticoagulant, fibrinolytic, and antithrombotic activities in vivo. Since Semax is neutral with respect to homeostasis parameters in vitro, it could be supposed that Semax hydrolysis to PGP is essential for its influence on fibrinolysis and thrombosis processes (Ashmarin et al., 1996) . PGP itself was reported to be classic glyproline with markedly expressed antithrombotic, fibrinolytic, and anticoagulant properties (Pastorova et al., 1998) .
Semax was shown to enhance gastric mucosal (GM) resistance to action of several ulcerogenic fac tors such as ethanol and stress. Inhibition of acetic ulcers formation, as well as increase in its healing, under the action of Semax was also reported (Zhui kova et al., 2000) .
It has been observed that Semax' half life is less than 1 h in the presence of plasmatic membranes from rat brain. Peptide biodegradation mainly occurs by deletion of the N end aminoacids from the primary nucleotide sequence. The main products of heptapep tide biodegradation are HFPGP, FPGP, and PGP with the prevalence of pentapeptide and tripeptide forms (Dolotov et al., 2004) .
PGP protective properties with respect to gastric mucosal (GM) were demonstrated on various classical experimental models of ulcerogenesis (Abramova et al., 1996; Samonina et al., 2000; Bakaeva, Samon ina, 2005) . PGP metabolites-PG and GP dipep tides-might be detected in rats' blood after 30 min (Zolotarev et al., 2003) be more effective on the models of gastric mucosal injury mainly caused by the disturbance in peripheral mechanisms of gastric homeostasis maintenance (Abramova et al., 1996) .
Since antiulcerogenic activity of other Semax metabolites has not been studied previously, the present study aimed to investigate the possible influ ence of these peptides on GM resistance to such injur ing factors as ethanol and stress, and to analyze the role of Semax derivatives with respect to formation of gastroprotective properties.
MATERIAL AND METHODS
Activity of Semax (MEHFPGP) and its metabo lites-HFPGP, FPGP, and PGP-synthesized at the Institute of Molecular Genetics of the Russian Acad emy of Sciences has been investigated via two experi mental models of ulcerogenesis: ethanol model in 0.06 and 0.37 µmol/kg doses and stress model in 0.06, 0.37 and 3.7 µmol/kg doses. Increase of Semax and its metabolites classic clinical dose (0.06 µmol/kg) to 0.37 and 3.7 µmol/kg allowed to compare antiulcerogenic effects of investigated peptides with glyproline effects (PGP, PG, and GP)-agents known for their antiul cerogenic properties.
In the first case, males from outbred white rates were used as model animals, while, in the second case, males from Wistar line with weight 200-300 g were investigated. Animals were deprived of food one day prior to the experiment, while those subjected to par ticipation in the ethanol model were also deprived of water, and placed into the chamber with lattice bottom for coprophagy prevention. Case and control animals were peritoneally injected either with the studied preparation or physiological solution in the quantity of 0.5 ml/200 g of weight one hour prior ulcerogenesis.
One hour after preparation injection, rats were either intragastrically injected with 1ml/200g of weight 96% ethanol or placed into water containing pool (water temperature was 21°C) for 30 min. Subse quently animals were wiped and placed into warm heated chambers. Animals were killed by ether after one hour.
Every ulcer area in mm 2 has been assessed via bin ocular with ocular micrometer. Summarized ulcer area was counted in every stomach. Since mean ulcer areas in control animals varied significantly in differ ent experiments, ulcer areas were normalized, i.e., were presented in percent to mean control meaning in every distinct experiment. Mean ulcer area was esti mated for every group, i.e., ulcer injury in percent to control one. Antiulcerogenic preparation action was presented as reverse number, i.e., percent explaining decrease in mean area of experimentally induced ulcers compared to control due to peptides action. Test of statistically significant differences between groups was carried out under Statistica 5.0 LSD test software.
Animal experiments were performed correspond ingly to bioethical principals and normative docu ments recommended by the European Science Foun dation and the Declaration of Helsinki of Humanic Relation to Animals.
RESULTS AND DISCUSSION
One hour after ethanol injection, large injuries on GM were detected involving significant widely stretching hemorrhages and erosions. In the case of stress model of ulcer induction, spot erosions on mucous membrane sized from 0.1 × 0.1 mm to 1 × 1 mm named stressor ulcers in the published data were gen erated.
Induction of ulcer injuries is caused by involvement of both peripheral and central mechanisms possessing different impact in stomach ulcerogenesis. Occur rence of ethanol induced ulcers in GM was shown to be mainly due to peripheral mechanisms of ulcerogen esis (Sibilia et al., 2003) , while stress influence of swimming in cold water was shown to be mainly due to the central mechanisms (Mayer, 2000) .
Ethanol model of ulcerogenesis. The group pre dominantly subjected to Semax injection in classic clinical doses of 0.06 µmol/kg was characterized by the occurrence of ethanol induced injury equal to 36% compared to the ulcer area equal to 100% in con trol animals (Fig. 1) . Antiulcerogenic effect comprised 64%. Slightly lower antiulcerogenic effect (60%) was observed in the case of FPGP tetrapeptide injection. HFPGP pentapeptide has not demonstrated any influence on ulcerogenesis.
Increase in Semax dose by six times resulted in no change in its gastroprotective action (Fig. 1) . Interest ingly, with an injection of penta and tetrapeptides in a 0.37 µmol/kg dose, the inversion of their action was Ulcer area, % 0.06 µmol/kg 0.37 µmol/kg Fig. 1 . Influence of Semax and its metabolites on ethanol induced ulcerogenesis in rats. *P < 0.05; **P < 0.01 com pared to control, n is the number of animals in the group. 1 is control, 2 is MEHFPGP, 3 is HFPGP, 4 is FPGP, and 5 is PGP.
* * ** ** detected. In the case of HFPGP, significant gastropro tective action (80%) was observed, while FPGP injec tion demonstrated only the tendency of this action. Gastroprotective effect of PGP tripeptide is known to be stable at the wide dose range from 0.5 to 53 µmol/kg. Analogous properties were shown for PG dipeptide, while GP dipeptide decreased ethanol induced inju ries only in the case of dose increase to 53 µmol/kg (Zhuikova et al., 2003) .
Probably, subsequent FPGP hydrolysis does not result in PGP metabolite synthesis since no action of this tetrapeptide used in classic dose 3.7 µmol/kg was observed (not shown in Fig. 1) , while markedly expressed antiulcerogenic activity was detected for tripeptide (Zhuikova et al., 2003) . FPGP effect, or its absence to be more precise, reminds of indifferent properties of GP with respect to injuries induced by peripheral mechanisms of ulcerogenesis. Hence, it might be supposed that the product of FPGP hydroly sis is GP characterized by the absence of ulceroprotec tive properties in the case of ethanol model of ulcero genesis. It could not be excluded that the methods used by authors (Dolotov et al., 2004) for investigation of Semax biodegradation in the presence of plasmatic membranes from rat's brain have not allowed to detect short dipeptides in the incubation mixture.
Accordingly, Semax protection of GM from etha nol induced injuries is probably defined by heptapep tide's action in total, while its metabolites were shown to possess their own dose dependent gastroprotective effects. Considering our previous findings, antiulcer activity was reported for such tetrapeptides as GPGG (Abramova et al., 1996) and GPGP (Baglikova et al., 2009) ; however, FPGP could not be referred to glyprolines due to the presence of phenylalanine in its molecule.
Stress water immersion model of ulcerogenesis. In the case of stress model, Semax was demonstrated to possess approximately equal antiulcerogenic activity at 0.06 and 0.37 µmol/kg doses-60%-while at 3.7 µmol/kg dose activity was 89% (Fig. 2) . This effect is 18% higher than the effect reported from the action of the mostly active to stress induced ulcers glyproline-GP dipeptide used in classic dose 3.7 µmol/kg (Zhuikova et al., 2003a) . Semax derivatives HFPGP and FPGP demonstrated significant gastroprotective effects at dose 0.06 µmol/kg-92 and 90%, respectively. Dose increase by either 6 or 60 times resulted in almost unchanged properties. Antiulcerogenic effects com parison between MEHFPGP and its metabolites-HFPGP, FPGP, and PGP-injected at 3.7 µmol/kg dose revealed reliably enhancement in GM resistance to stress action with the maximal tendency in effec tiveness for MEHFPGP.
Accordingly, Semax metabolites-HFPGP and FPGP-were demonstrated to possess their own gas troprotective potential at the large range of dosesfrom 0.06 to 3.7 µmol/kg-in the case of peritoneal injection and might be involved into MEHFPGP pro tective properties directed to the stomach mucous membrane against stress action. Significantly large protective percent of heptapeptide injection was revealed only using the largest acceptable dose.
Thus, revealed data confirms the presence of Semax's gastroprotective properties under both peripheral and central level. The main mechanisms of antiulcero genic Semax action might include its influence on blood flow (Zhuikova et al., 2002) , on stomach secre tion (Zhuikova et al., 2003a, b) , and on CNS (Yas netsov et al., 1995; Ashmarin et al., 1997) .
It should be supposed that antiulcerogenic Semax activity directed to injuries induced by peripheral mechanisms of ulcerogenesis is mainly determined by the effects of heptapetide itself and does not depend on hydrolysis products. Gastroprtotective action of MEHFPGP directed to the ulcer induced by central disturbances in gastric mucosal homeostasis might be related to HFPGP and PGP metabolites release. 
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